Aurobindo Pharma Q3 PBT rises 6% to Rs 942.8 cr; revenues up 11.9%

Aurobindo Pharma Limited on Thursday reported a 6 per cent increase in profit before tax (PBT) at Rs 942.8 crore for the quarter ended December, 2019, as compared to Rs 889 crore in the corresponding period of 2018, driven by a healthy revenue growth in the US market.

The company's revenues grew 11.9 per cent at Rs 5,895 crore in the quarter under review as compared to Rs 5,269.7 crore in the year ago period. The formulations revenues for the quarter posted a growth of 17.4 per cent year-on-year at Rs 5,104 crore, accounting for 86.6 per cent of the total